Tempus is a health-tech startup that builds the infrastructure to modernize cancer treatment. Recently, the Dartmouth research team conducted a study to display the three new lung cancer genetic biomarkers. As a result, the variation in the humans DNA underlies the susceptibility of developing diseases. Additionally, two more for non-small cell lung cancer risk and one SNP for squamous cell lung cancer risk.
The three variations are possible biomarkers applied to develop the accuracy to which researchers can characterize an individual’s danger of lung cancer disease by puffing behavior, which holds helpful for individualized diagnosis and prognostication of a medication program. The Dartmouth team supposes that the grown genotype data becomes accessible in the future; the team can learn more notable gene-smoking interaction in cancer epidemic.
Eric Lefkofsky, the founder of Groupon and one of Chicago’s most influential tech figures, has donated millions of dollars toward cancer research during his life. Now, he’s behind a startup that wants to take a smarter approach to the race to preventive measures of cancer.
Eric Paul Lefkofsky is an American born entrepreneur since the year 1969. He went to the University of Michigan and acquired a degree in law from University of Michigan Law School. Eric is also a co-founder and Chief Executive Officer of Tempus. Eric also co-founds other companies such as the Groupon, Echo Global Logistics, Inner Workings, Mediaocean, and Uptake. He also heads the mentioned companies as the sole chairman. Eric also cofounds the Chicago-based venture capital firm, Lightbank, a venture fund investing in disruptive technologies.
In addition to his success, Eric Lefkofsky has contributed to charity by founding the Lefkofsky Family Foundation. The charity organization primarily focuses on supporting scientific and educational institutions and causes around the world. The foundation has helped fund more than fifty organizations. Additionally, Eric Lefkofsky contributes to the Giving Pledge, a nonprofit organization.
Lefkofsky serves as a board of Trustee at the Chicago based, Lurie Children’s Hospital. Additionally, he is also a board member of the Art Institute of Chicago, The Museum of Science and Industry, World Business Chicago and Chicago’s Steppenwolf Theatre Company. Lefkofsky is a professor at the University of Chicago and author of Accelerated Disruption. Lefkofsky is currently a Professor at the University Of Chicago Booth School Of Business. He teaches a course on entrepreneurship and building technology-based businesses. In honor of his success, Easton Studio Press published Lefkofsky Accelerated Disruption book about how technology affects business.